Treating GEFS+: Daily Care and Emergency Response
At a Glance
GEFS+ treatment depends on seizure type, frequency, and duration. Brief fever-related seizures may not need daily medicine, but seizures without fever or frequent or prolonged events may. A written plan should explain rescue medicine use and when a 5-minute convulsive seizure needs emergency help.
Managing Genetic Epilepsy with Febrile Seizures Plus (GEFS+) is a balancing act. Because the condition is a spectrum, there is no “one-size-fits-all” treatment. Your care team will tailor a plan based on your child’s specific seizure types, how often they happen, and their genetic results [1][2].
Daily Management: To Treat or Not to Treat?
The decision to start a daily anti-seizure medication (also called a maintenance or prophylactic medication) depends on the “burden” of the seizures.
- Observation and Reassurance: If your child only has isolated febrile seizures that are brief and infrequent, daily medication is usually not recommended [3]. In these cases, the risks and side effects of daily drugs often outweigh the benefits, as these seizures are usually self-limited and outgrown [3][4]. (Note that while fever-reducing medicines may improve comfort, they do not reliably prevent febrile seizures.)
- When Medication is Considered: Your doctor may recommend daily treatment if your child develops afebrile seizures (seizures without fever), experiences multiple different seizure types, or has very frequent or prolonged events [1][2]. The goal of daily medication is not necessarily to “cure” the epilepsy, but to reduce the number of seizures and improve your child’s quality of life [5].
The Sodium-Channel Blocker Nuance
A unique challenge in GEFS+ (especially when SCN1A is involved) is the use of a class of drugs called sodium-channel blockers (such as carbamazepine, oxcarbazepine, or lamotrigine).
- The Risk of Aggravation: In many SCN1A mutations—particularly those seen in Dravet syndrome—these drugs can aggravate seizures [6][7].
- The Exception: In some milder forms of GEFS+, these same medications might actually be helpful [8][9]. The functional effect of a variant is often unknown on standard lab reports.
Because of this, it is vital that a specialist reviews your child’s phenotype before starting or avoiding these specific medications [10]. Never start, stop, or avoid an antiseizure medication based on this guide; always consult your doctor.
Managing Seizure Emergencies
While most seizures end on their own within a minute or two, any convulsive seizure lasting 5 minutes or more is considered a medical emergency called status epilepticus [11][12].
Seizure First Aid Protocol:
- Start timing the seizure immediately.
- Protect the child from injury (move hard objects away, place something soft under the head).
- Turn them on their side if possible to keep the airway clear.
- Do NOT restrain their movements.
- Do NOT put anything in their mouth.
Rescue Medications
Your doctor will likely provide a Seizure Action Plan that includes a “rescue medication.” These are fast-acting drugs designed to stop a seizure in progress. Common options include:
- Buccal Midazolam: A liquid placed between the cheek and the gum [13].
- Intranasal Midazolam: A spray into the nose [14].
- Rectal Diazepam: A gel administered rectally [13].
These are typically given if a convulsive seizure reaches the 5-minute mark, though your doctor may set a specific threshold for your child [12][13]. Call your local emergency number if the seizure continues, if the child has trouble breathing, or if they suffer repeated seizures without recovering.
After the Seizure: What to Watch For
Most children are sleepy or confused after a seizure (the post-ictal state). However, if your child remains unresponsive for a prolonged time, fails to return toward baseline, or shows difficulty breathing, they require urgent evaluation. Prolonged confusion with subtle signs might occasionally indicate non-convulsive status epilepticus, a condition that requires formal clinical assessment and an EEG to diagnose—it is not something a parent can diagnose at home [15][16][17].
Safety and Support
The most effective tool you have is a written Seizure Action Plan [13]. This document should clearly state your child’s weight-based rescue dose, when to give it, and exactly when to call emergency services [12]. Sharing this with teachers, family members, and caregivers ensures your child is safe no matter where they are.
Common questions in this guide
Does every child with GEFS+ need a daily seizure medicine?
Can some seizure medicines make GEFS+ seizures worse?
What should I do first when my child's seizure begins?
When should I give my child's rescue medicine?
How can I tell if my child needs urgent care after a seizure?
What should a GEFS+ Seizure Action Plan include?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Get notified when new evidence is published on Genetic epilepsy with febrile seizure plus.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my child's genetic variant have a known functional effect, and how does that specific information guide our choice of medication?
- 2.Given my child's current seizure frequency, are we at the point where the benefits of daily medication outweigh the potential side effects?
- 3.If we use a rescue medication like midazolam, at exactly how many minutes should I administer it, and when should I call emergency services?
- 4.Can you help me create a written Seizure Action Plan that I can share with my child's school or daycare?
- 5.How will we know if my child is experiencing 'non-convulsive' status epilepticus, and what should I look for after a seizure ends?
- 6.Are there specific 'red flag' medications that we should absolutely avoid at the pharmacy or if we end up in an emergency room?
References
References (17)
- 1
Genetic literacy series: genetic epilepsy with febrile seizures plus.
Myers KA, Scheffer IE, Berkovic SF,
Epileptic disorders : international epilepsy journal with videotape 2018; (20(4)):232-238 doi:10.1684/epd.2018.0985.
PMID: 30078767 - 2
Genetic epilepsy with febrile seizures plus: Refining the spectrum.
Zhang YH, Burgess R, Malone JP, et al.
Neurology 2017; (89(12)):1210-1219 doi:10.1212/WNL.0000000000004384.
PMID: 28842445 - 3
Febrile seizures and genetic epilepsy with febrile seizures plus (GEFS+).
Camfield P, Camfield C
Epileptic disorders : international epilepsy journal with videotape 2015; (17(2)):124-33 doi:10.1684/epd.2015.0737.
PMID: 25917466 - 4
Outcomes and comorbidities of SCN1A-related seizure disorders.
de Lange IM, Gunning B, Sonsma ACM, et al.
Epilepsy & behavior : E&B 2019; (90()):252-259 doi:10.1016/j.yebeh.2018.09.041.
PMID: 30527252 - 5
Clinical and genetics spectrum of 392 Chinese patients with genetic epilepsy with febrile seizures plus.
Chen S, Quan Y, Yin F, Peng J
Journal of neurology 2025; (273(1)):18.
PMID: 41366559 - 6
From Symptomatic Therapies to Disease-Modifying Approaches for Neuronal Sodium Channel Disorders.
Dinoi G, Canfora I, D'Agnano D, et al.
International journal of molecular sciences 2025; (27(1)) doi:10.3390/ijms27010032.
PMID: 41515912 - 7
Acute effect of antiseizure drugs on background oscillations in Scn1a A1783V Dravet syndrome mouse model.
Quinn S, Brusel M, Ovadia M, Rubinstein M
Frontiers in pharmacology 2023; (14()):1118216 doi:10.3389/fphar.2023.1118216.
PMID: 37021051 - 8
The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications.
Brunklaus A, Brünger T, Feng T, et al.
Brain : a journal of neurology 2022; (145(11)):3816-3831 doi:10.1093/brain/awac210.
PMID: 35696452 - 9
Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication.
Matricardi S, Cestèle S, Trivisano M, et al.
Epilepsia 2023; (64(5)):1331-1347 doi:10.1111/epi.17509.
PMID: 36636894 - 10
Epilepsy-associated Variants of a Single SCN1A Codon exhibit Divergent Functional Properties.
Liebovitz LN, Thompson CH, Laux LL, George AL
bioRxiv : the preprint server for biology 2025; doi:10.1101/2025.10.16.682932.
PMID: 41279753 - 11
Optimal Management of Status Epilepticus in Children in the Emergency Setting: A Review of Recent Advances.
Messahel S, Bracken L, Appleton R
Open access emergency medicine : OAEM 2022; (14()):491-506 doi:10.2147/OAEM.S293258.
PMID: 36158897 - 12
Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesis.
Cruickshank M, Imamura M, Booth C, et al.
Health technology assessment (Winchester, England) 2022; (26(20)):1-76 doi:10.3310/RSVK2062.
PMID: 35333156 - 13
Recommendations for the community-based management of prolonged convulsive seizures in children in Europe.
Vigevano F, Arzimanoglou A, Auvin S, et al.
BMC pediatrics 2026; (26(1)):135.
PMID: 41593567 - 14
Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults: Report of the Guideline Committee of the American Epilepsy Society.
Glauser T, Shinnar S, Gloss D, et al.
Epilepsy currents 2016; (16(1)):48-61 doi:10.5698/1535-7597-16.1.48.
PMID: 26900382 - 15
Nonconvulsive status epilepticus after cessation of convulsive status epilepticus in pediatric intensive care unit patients.
Chen J, Xie L, Hu Y, et al.
Epilepsy & behavior : E&B 2018; (82()):68-73 doi:10.1016/j.yebeh.2018.02.008.
PMID: 29587188 - 16
Clinical Features and Management of Status Epilepticus in the Pediatric Intensive Care Unit.
Soydan E, Guzin Y, Topal S, et al.
Pediatric emergency care 2023; (39(3)):142-147 doi:10.1097/PEC.0000000000002915.
PMID: 36790917 - 17
EEG Monitoring After Convulsive Status Epilepticus.
Fung FW, Abend NS
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2020; (37(5)):406-410 doi:10.1097/WNP.0000000000000664.
PMID: 32890062
This page is for informational purposes only and does not constitute medical advice. A child's neurologist or other clinician should individualize GEFS+ medicines, rescue-medication timing, and emergency instructions for your child.